ID   NOS2SNR
AC   CVCL_RN30
DR   Wikidata; Q54930919
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T747 ! NOS2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
RX   PubMed=8978593; DOI=10.1159/000227661;
RA   Wakahara Y., Nawa A., Okamoto T., Hayakawa A., Kikkawa F.,
RA   Suganama N., Wakahara F., Tomoda Y.;
RT   "Combination effect of anti-Fas antibody and chemotherapeutic drugs in
RT   ovarian cancer cells in vitro.";
RL   Oncology 54:48-54(1997).
//